Physicochemical and microbiological stability of insulin eye drops in an artificial tear vehicle used in the treatment of refractory neurotrophic keratopathy.

Collyre à insuline Container-content interaction Insulin Interaction contenant-contenu Kératite neurotrophique Neurotrophic keratopathy Ophthalmic solution Physicochemical microbiological stability Solution ophtalmique Stabilité physico-chimique et microbiologique

Journal

Journal francais d'ophtalmologie
ISSN: 1773-0597
Titre abrégé: J Fr Ophtalmol
Pays: France
ID NLM: 7804128

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 31 03 2022
revised: 14 04 2022
accepted: 21 04 2022
pubmed: 2 8 2022
medline: 4 10 2022
entrez: 1 8 2022
Statut: ppublish

Résumé

Neurotrophic keratopathy (NK) is a degenerative corneal disease with a loss of corneal sensitivity and impairment of corneal healing. Low dose insulin eyedrops have been shown to be a simple and effective treatment for refractory NK when the response to the usual treatment is incomplete. At present, there are no commercially available forms, and there is no data regarding the stability of these products as prepared by compounding pharmacies. In this work, we studied the physicochemical and microbiological stability of an insulin ophthalmic formulation obtained by mixing insulin lispro in artificial tears with a polyethylene and propylene glycol base. The stability of this 1IU/mL insulin ophthalmic formulation was analysed for 12 months in low-density polyethylene (LDPE) multidose eye droppers at 4°C. The studied parameters of physicochemical stability were: visual inspection, turbidity, UV spectral absorption, osmolality and pH. In addition, insulin and m-cresol concentrations and quantification of impurities (insulin covalent aggregates and insulin fragments) were studied thanks to the development of a new Size Exclusion Chromatographic method. For unopened eye droppers, all tested physicochemical parameters remained stable for 12 months at 4°C, and excellent microbiological stability was obtained. In conditions of simulated use, these parameters also remained stable for one month at 4°C, and no impact of potential temperature rises on the insulin and m-cresol concentrations in the insulin eyedropper was observed.

Identifiants

pubmed: 35914962
pii: S0181-5512(22)00258-3
doi: 10.1016/j.jfo.2022.04.008
pii:
doi:

Substances chimiques

Cresols 0
Insulin Lispro 0
Lubricant Eye Drops 0
Ophthalmic Solutions 0
Propylene Glycols 0
Polyethylene 9002-88-4
3-cresol GGO4Y809LO

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

860-871

Informations de copyright

Copyright © 2022 Elsevier Masson SAS. All rights reserved.

Auteurs

M H Le Nguyen (MH)

Pôle pharmaceutique, CHU Jean Minjoz, 2 boulevard Fleming, 25030 Besançon, France.

M S Naoum (MS)

Service d'ophtalmologie, CHU Jean Minjoz, 2 boulevard Fleming, 25030 Besançon, France.

C Andre (C)

Pôle chimie analytique et physique, EA 481 « Neurosciences Intégratives et Cliniques », UFR Santé, université Bourgogne Franche-Comté, 25030 Besançon, France.

L Lethier (L)

Pôle chimie analytique et physique, EA 481 « Neurosciences Intégratives et Cliniques », UFR Santé, université Bourgogne Franche-Comté, 25030 Besançon, France.

S Limat (S)

Pôle pharmaceutique, CHU Jean Minjoz, 2 boulevard Fleming, 25030 Besançon, France; Inserm, EFS BFC, UMR 1098, université Bourgogne Franche-Comté, 25030 Besançon, France.

C Fagnoni-Legat (C)

Pôle pharmaceutique, CHU Jean Minjoz, 2 boulevard Fleming, 25030 Besançon, France.

Y Guillaume (Y)

Pôle pharmaceutique, CHU Jean Minjoz, 2 boulevard Fleming, 25030 Besançon, France; Pôle chimie analytique et physique, EA 481 « Neurosciences Intégratives et Cliniques », UFR Santé, université Bourgogne Franche-Comté, 25030 Besançon, France.

A S Gauthier (AS)

Service d'ophtalmologie, CHU Jean Minjoz, 2 boulevard Fleming, 25030 Besançon, France; Faculté de médecine, université Bourgogne Franche-Comté, 25030 Besançon, France; Inserm, EFS BFC, UMR 1098, université Bourgogne Franche-Comté, 25030 Besançon, France. Electronic address: asgauthier@chu-besancon.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH